Gas6 expression is reduced in advanced breast cancers

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Growth arrest-specific gene 6 (Gas6) is a cytokine that interacts with receptor tyrosine kinases Tyro3, Axl, and Mer.
• Macrophage-derived Gas6 and its interaction with Axl have been implicated in promoting cancer progression and are associated with poor clinical outcomes.
• The expression and clinical relevance of Gas6 in human breast cancer patients remain understudied.

Purpose of the Study:

• To investigate the expression pattern of Gas6 in different stages of human breast cancer.
• To determine the correlation between Gas6 and Axl expression in breast cancer.
• To evaluate the prognostic significance of Gas6 in breast cancer patients.

Main Methods:

• Analysis of Gas6 expression in breast cancer tissues using tissue microarrays.
• Assessment of the correlation between Gas6 and Axl expression.
• Examination of publicly available gene expression databases to correlate Gas6 mRNA levels with patient survival outcomes (overall and relapse-free survival).

Main Results:

• Gas6 was found to be highly expressed in ductal carcinoma in situ (DCIS) but significantly decreased in invasive breast cancer.
• A weak correlation was observed between Gas6 and Axl expression, suggesting independent functions.
• High Gas6 mRNA levels were associated with significantly improved overall and relapse-free survival, particularly in luminal A breast cancer subtypes.

Conclusions:

• Tumor-derived Gas6 is not overexpressed in invasive human breast cancer.
• Gas6 expression is associated with favorable clinical outcomes in breast cancer patients, particularly in luminal A subtypes.
• Gas6 may not serve as a negative prognostic factor in human breast cancer and could potentially have a protective role in certain contexts.